NLRP3 and infection: SARS‐Cov‐2 E protein may inhibit the host NLRP3 inflammasome response to viral RNA in the early stage of infection, but it will increase NLRP3 inflammasome response in the later stage of infection, and eventually induce severe inflammatory response.